EHC
Encompass Health Corporation · Healthcare · Medical - Care Facilities
Señales de momentum (gestores comparables):
amplitud de titulares +9.1% ·
flujo de acciones +3.2% ·
nuevas posiciones netas +4.2%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 131 | -3 | 69.23M | $6.99B | +2 | −6 |
| Q1 2026 | 138 | +3 | 68.76M | $6.68B | +9 | −7 |
| Q4 2025 | 136 | -2 | 75.50M | $8.01B | +1 | −2 |
| Q3 2025 | 24 | +2 | 41.27M | $5.24B | +2 | −1 |
| Q2 2025 | 20 | +2 | 37.20M | $4.56B | +2 | n/a |
| Q1 2025 | 15 | 0 | 14.75M | $1.49B | n/a | n/a |
| Q4 2024 | 15 | 0 | 14.46M | $1.34B | +1 | −1 |
| Q3 2024 | 14 | +3 | 13.62M | $1.32B | +3 | n/a |
| Q2 2024 | 11 | n/a | 14.78M | $1.27B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 10.24M | -1.4% | $1.30B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasivo) | 9.88M | 0.0% | $1.25B | 0.0% | ▲ Add | 2 | SEC ↗ ×19 |
| 3 | T. Rowe Price ✦ | 3.86M | +174.0% | $489.94M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (pasivo) | 3.08M | -0.8% | $391.41M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | JPMorgan Chase ✦ | 2.82M | n/a | $358.28M | 0.0% | n/c | 1 | SEC ↗ ×24 |
| 6 | Wellington Management ✦ | 2.78M | -21.1% | $353.29M | 0.1% | ▼ Trim | 6 | SEC ↗ ×7 |
| 7 | Geode Capital Management ✦ (pasivo) | 1.81M | +2.0% | $229.73M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 1.22M | +140.0% | $155.43M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 1.07M | +3.4% | $135.58M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 1.05M | -38.0% | $133.70M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 11 | Morgan Stanley ✦ | 788.21K | n/a | $100.12M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 12 | AQR Capital Management ✦ | 645.28K | +47.5% | $81.70M | 0.1% | ▲ Add | 6 | SEC ↗ ×5 |
| 13 | Two Sigma Investments ✦ | 505.64K | +0.3% | $64.23M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 14 | Goldman Sachs Group ✦ | 332.66K | n/a | $42.25M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | Citadel Advisors ✦ | 311.65K | -68.2% | $39.59M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Adage Capital Partners ✦ | 284.17K | +4.2% | $36.10M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 17 | Glenview Capital ✦ | 167.64K | Nuevo | $21.29M | 0.5% | New | 1 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 144.39K | +135.9% | $18.34M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 86.22K | -69.5% | $10.95M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 20 | Renaissance Technologies ✦ | 71.00K | +35.5% | $9.02M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 62.72K | -60.9% | $7.97M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 57.80K | +1671.3% | $7.34M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | GAMCO Investors ✦ | 4.77K | -0.5% | $606,139 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Point72 Asset Management ✦ | 420 | Nuevo | $53,348 | 0.0% | New | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Glenview Capital | $21.29M | 0.5% |
| Point72 Asset Management | $53,348 | 0.0% |
Posición cerrada
| Norges Bank | $139.54M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 577 tenedores, 95.06M acciones, $8.15B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 4.86K acc. · $588,255
Officer · 5.21K acc. · $630,166
Officer · 18.87K acc. · $2.37M
Officer, Director · 1.58K acc. · $199,049
Officer · 8.91K acc. · $1.12M
Officer, Director · 171.57K acc. · $21.53M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología